Corcept Therapeutics Incorporated · NASDAQ:CORT

Wilson James N sold 10,000 Corcept Therapeutics Incorporated shares (Form 4)

Traded Sep 15, 2026 · Filed Sep 16, 2026

On Sep 15, 2026, Wilson James N (Director) sold 10,000 Corcept Therapeutics Incorporated shares at an average US$110.69 for US$1.11M under a trading plan, leaving 1,064,543 shares. Filed Sep 16, 2026 (Form 4).

Sold
10,000 shares
Price
US$110.69 average (US$110.27 to US$111.70)
Value
US$1.11M
Holding after
1,064,543 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 15, 2026Common StockSale6,800US$110.271,067,743Indirect
Sep 15, 2026Common StockSale400US$110.841,067,343Indirect
Sep 15, 2026Common StockSale2,800US$111.701,064,543Indirect

Source

View original at SEC

Related